NEUROONE MEDICAL TECHNOLOGIES CorpNMTC
Market cap
$35.8M
P/E ratio
| 2011/12 | 2014/12 | 2015/12 | 2016/12 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Cash and cash equivalents | - | - | - | - | 260,749 | 4 | 7 | 8 | 5 | 1 |
| Marketable securities, current | - | - | - | - | - | - | - | 3 | - | - |
| Total cash & short-term investments | - | - | - | - | 260,749 | 4 | 7 | 11 | 5 | 1 |
| Accounts receivable, net | - | - | - | - | - | - | 48,336 | 33,237 | - | 176,636 |
| Inventories | - | - | - | - | - | - | 98,287 | 704,538 | 2 | 3 |
| Total current assets | 13,851 | 205 | 1,838 | - | 301,751 | 4 | 7 | 12 | 7 | 5 |
| Property, plant and equipment, net | - | - | - | - | 52,026 | 166,031 | 223,329 | 353,599 | 525,753 | 416,843 |
| Total non-current assets | - | - | - | - | 230,864 | 604,765 | 646,484 | 646,846 | 784,389 | 739,015 |
| Total assets | 13,851 | 205 | 1,838 | 4,277 | 532,615 | 5 | 8 | 13 | 8 | 5 |
| Accounts payable | - | 9,966 | 16,659 | 22,362 | 1 | 762,538 | 528,829 | 927,662 | 685,104 | 1 |
| Total current liabilities | 4,628 | 35,594 | 83,330 | 117,927 | 2 | 2 | 1 | 3 | 2 | 2 |
| Total non-current liabilities | 12,500 | - | - | - | - | 337,661 | 202,895 | 119,556 | 55,284 | 2 |
| Total liabilities | 17,128 | 35,594 | 83,330 | 117,927 | 2 | 3 | 1 | 3 | 2 | 5 |
| Common stock and paid-in capital | 33,150 | 81,796 | 50,650 | 50,650 | 16 | 33 | 47 | 60 | 69 | 76 |
| Retained earnings | - | - | -180,048 | -227,823 | -17,238,871 | -30,879,031 | -40,827,199 | -50,826,812 | -62,686,303 | -75 |
| Stockholders' equity | -3,277 | -35,389 | -81,492 | -113,650 | -1,237,578 | 2 | 7 | 10 | 6 | 822,013 |
| Working capital | - | - | - | - | - | - | - |